KennethRHallowsMDPhD, FASN
Nephrology • Los Angeles, CAProfessor of Medicine; Chief, Division of Nephrology and Hypertension; Director, USC/UKRO Kidney Research Center / University of Southern California Keck School of Medicine
Dr. Hallows is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2020 Zonal Av.
IRD 806
Los Angeles, CA 90033Phone+1 323-442-1040- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Nephrology, 1997 - 2001- University of Pennsylvania Health SystemResidency, Internal Medicine, 1995 - 1997
University of Rochester School of Medicine and DentistryClass of 1995
Brown UniversitySc.B., Biophysics, Magna cum Laude, 1983 - 1987
Certifications & Licensure
CA State Medical License 2015 - 2025
PA State Medical License 1996 - 2016- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
Clinical Trials
- Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2016 Jun 27
Publications & Presentations
PubMed
- 2 citationsModeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoids.Biao Huang, Zipeng Zeng, Hui Li, Zexu Li, Xi Chen, Jinjin Guo, Chennan C Zhang, Megan E Schreiber, Ariel C Vonk, Tianyuan Xiang, Tadrushi Patel, Yidan Li, Riana K Parv...> ;Biorxiv. 2023 May 25
- 2 citationsAssociation of Longitudinal Urinary Metabolic Biomarkers With ADPKD Severity and Response to Metformin in TAME-PKD Clinical Trial Participants.Kenneth R Hallows, Kaleab Z Abebe, Hui Li, Biagio Saitta, Andrew D Althouse, Kyongtae T Bae, Christina M Lalama, Dana C Miskulin, Ronald D Perrone, Stephen L Seliger, ...> ;Kidney International Reports. 2023 Mar 1
- 4 citationsIn vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease.Alysia Cox, Madelynn Tung, Hui Li, Kenneth R Hallows, Eun Ji Chung> ;SLAS Technology. 2023 Aug 1
- Join now to see all
Journal Articles
- Design and in vivo characterization of kidney-targeting peptide amphiphile micelles toward renal drug deliveryWang, J., Poon, C., Chin, D., Milkowski, S., Lu, V., Hallows, K.R., and Chung, E.J., Nano Res. 11(10): 5584-5595, 2018.
- Muc1 is protective during kidney ischemia-reperfusion injuryPastor-Soler, N.M., Sutton, T.A., Mang, H.E., Kinlough, C.L., Gendler, S.J., Madsen, C.S., Bastacky, S., Ho, J., Al-bataineh, M.M., Hallows, K.R., Singh, S., Monga, S...., Am. J. Physiol. Renal Physiol.
Authored Content
- MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney InjurySeptember 2018
Press Mentions
World Kidney Day: Keck Medicine of USC Experts Discuss Kidney Health and ResearchMarch 8th, 2017
MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney InjurySeptember 19th, 2018
Grant Support
- Effects of Combination Therapy with Tolvapatan and the Farnesoid X Receptor Agonist INT-747 on Hepatotoxicity, Metabolic and Injury Biomarkers, and Cystogenesis in ADPKDOtsuka Pharmaceuticals, Inc.2019–2020
- Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (Clinical Trial Award)U.S. Department of Defense2015–2020
- Cellular Energy Pathways as Novel Targets for the Therapy of Autosomal Dominant Polycystic Kidney DiseaseU.S. Department of Defense2015–2018
- Mechanisms and Relevance of Sodium Transport Regulation by AMPKNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2012–2017
- Mechanisms And Relevance Of ENAC Regulation By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Mechanisms Of ENAC Regulation By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Mechanism Of Inhibition Of CFTR By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Mechanism Of Inhibition Of CFTR By AMP-ACTIVATED KinaseNational Institute Of Diabetes And Digestive And Kidney Diseases2001
- Novel Interaction Of Amp-Kinase With CFTR C1 ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases2000
- Novel Interaction Of Amp-Kinase With CFTR CL ChannelNational Institute Of Diabetes And Digestive And Kidney Diseases1999
Professional Memberships
- Fellow
Hospital Affiliations
Keck Hospital of USCLos Angeles, California
USC Norris Comprehensive Cancer CenterLos Angeles, California
Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
